Commonwealth Equity Services’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151K | Sell |
17,079
-1,685
| -9% | -$14.9K | ﹤0.01% | 3989 |
|
|
2025
Q1 | $147K | Sell |
18,764
-18,960
| -50% | -$149K | ﹤0.01% | 3921 |
|
|
2024
Q4 | $396K | Sell |
37,724
-6,264
| -14% | -$65.8K | ﹤0.01% | 3162 |
|
|
2024
Q3 | $577K | Sell |
43,988
-779
| -2% | -$10.2K | ﹤0.01% | 2771 |
|
|
2024
Q2 | $629K | Buy |
44,767
+5,460
| +14% | +$76.7K | ﹤0.01% | 2639 |
|
|
2024
Q1 | $664K | Sell |
39,307
-40,875
| -51% | -$690K | ﹤0.01% | 2575 |
|
|
2023
Q4 | $1.13M | Buy |
80,182
+969
| +1% | +$13.7K | ﹤0.01% | 2093 |
|
|
2023
Q3 | $816K | Buy |
79,213
+2,528
| +3% | +$26K | ﹤0.01% | 2217 |
|
|
2023
Q2 | $1.26M | Buy |
76,685
+32,150
| +72% | +$530K | ﹤0.01% | 1931 |
|
|
2023
Q1 | $407 | Buy |
44,535
+3,904
| +10% | +$36 | ﹤0.01% | 2723 |
|
|
2022
Q4 | $290K | Buy |
40,631
+7,942
| +24% | +$56.7K | ﹤0.01% | 2888 |
|
|
2022
Q3 | $163K | Buy |
32,689
+17,000
| +108% | +$84.8K | ﹤0.01% | 3253 |
|
|
2022
Q2 | $38K | Sell |
15,689
-447
| -3% | -$1.08K | ﹤0.01% | 3519 |
|
|
2022
Q1 | $110K | Buy |
16,136
+1,000
| +7% | +$6.82K | ﹤0.01% | 3461 |
|
|
2021
Q4 | $122K | Sell |
15,136
-1,621
| -10% | -$13.1K | ﹤0.01% | 3418 |
|
|
2021
Q3 | $164K | Sell |
16,757
-2,120
| -11% | -$20.7K | ﹤0.01% | 3331 |
|
|
2021
Q2 | $127K | Sell |
18,877
-1,700
| -8% | -$11.4K | ﹤0.01% | 3368 |
|
|
2021
Q1 | $186K | Buy |
20,577
+6,650
| +48% | +$60.1K | ﹤0.01% | 3151 |
|
|
2020
Q4 | $93K | Sell |
13,927
-850
| -6% | -$5.68K | ﹤0.01% | 3073 |
|
|
2020
Q3 | $74K | Buy |
14,777
+535
| +4% | +$2.68K | ﹤0.01% | 2915 |
|
|
2020
Q2 | $115K | Buy |
+14,242
| New | +$115K | ﹤0.01% | 2748 |
|